These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34411375)

  • 1. Reactions on Twitter towards Australia's proposed import restriction on nicotine vaping products: a thematic analysis.
    Sun T; Lim CCW; Gartner C; Connor JP; Hall WD; Leung J; Stjepanović D; Chan GCK
    Aust N Z J Public Health; 2021 Dec; 45(6):543-545. PubMed ID: 34411375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-Cigarette Advocates on Twitter: Content Analysis of Vaping-Related Tweets.
    McCausland K; Maycock B; Leaver T; Wolf K; Freeman B; Jancey J
    JMIR Public Health Surveill; 2020 Oct; 6(4):e17543. PubMed ID: 33052130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public Reactions to the New York State Policy on Flavored Electronic Cigarettes on Twitter: Observational Study.
    Sun L; Lu X; Xie Z; Li D
    JMIR Public Health Surveill; 2022 Feb; 8(2):e25216. PubMed ID: 35113035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-Cigarette Promotion on Twitter in Australia: Content Analysis of Tweets.
    McCausland K; Maycock B; Leaver T; Wolf K; Freeman B; Thomson K; Jancey J
    JMIR Public Health Surveill; 2020 Nov; 6(4):e15577. PubMed ID: 33151159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Impact of FDA Flavor Enforcement Policy on Vaping Behavior on Twitter.
    Xie Z; Ruan J; Jiang Y; Zhang B; Chen T; Luo J; Li D
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Perceptions on the Policy of Electronic Cigarettes as Medical Products on Twitter.
    Lou X; Liu P; Xie Z; Li D
    Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36767983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand.
    Erku DA; Kisely S; Morphett K; Steadman KJ; Gartner CE
    Int J Drug Policy; 2020 Apr; 78():102699. PubMed ID: 32086156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products.
    Levy DT; Gartner C; Liber AC; Sánchez-Romero LM; Yuan Z; Li Y; Cummings KM; Borland R
    Nicotine Tob Res; 2023 Feb; 25(3):486-497. PubMed ID: 36073731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Policy Debates Regarding Nicotine Vaping Products in Australia: A Qualitative Analysis of Submissions to a Government Inquiry from Health and Medical Organisations.
    Erku DA; Morphett K; Steadman KJ; Gartner CE
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31752132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Misuse of the Precautionary Principle in Justifying Australia's Ban on the Sale of Nicotine Vaping Products.
    Morphett K; Hall W; Gartner C
    Nicotine Tob Res; 2021 Jan; 23(1):14-20. PubMed ID: 32909044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public Perception of the Tobacco 21 Amendment on Twitter in the United States: Observational Study.
    Schneller-Najm LM; Xie Z; Chen J; Lee S; Xu E; Li D
    JMIR Infodemiology; 2024 Sep; 4():e53899. PubMed ID: 39321452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. #FlavorsSaveLives: An Analysis of Twitter Posts Opposing Flavored E-cigarette Bans.
    Kirkpatrick MG; Dormanesh A; Rivera V; Majmundar A; Soto DW; Chen-Sankey JC; Cruz TB; Unger JB; Allem JP
    Nicotine Tob Res; 2021 Aug; 23(8):1431-1435. PubMed ID: 33394024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-Cigarette-Related Nicotine Misinformation on Social Media.
    Sidani JE; Hoffman BL; Colditz JB; Melcher E; Taneja SB; Shensa A; Primack B; Davis E; Chu KH
    Subst Use Misuse; 2022; 57(4):588-594. PubMed ID: 35068338
    [No Abstract]   [Full Text] [Related]  

  • 14. Social Listening: A Content Analysis of E-Cigarette Discussions on Twitter.
    Cole-Lewis H; Pugatch J; Sanders A; Varghese A; Posada S; Yun C; Schwarz M; Augustson E
    J Med Internet Res; 2015 Oct; 17(10):e243. PubMed ID: 26508089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia.
    Erku DA; Gartner CE; Tengphakwaen U; Morphett K; Steadman KJ
    Drug Alcohol Rev; 2019 Sep; 38(6):703-711. PubMed ID: 31486151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twitter Misinformation Discourses About Vaping: Systematic Content Analysis.
    Al-Rawi A; Blackwell B; Zemenchik K; Lee K
    J Med Internet Res; 2023 Nov; 25():e49416. PubMed ID: 37948118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a mixed methods approach to identify public perception of vaping risks and overall health outcomes on Twitter during the 2019 EVALI outbreak.
    Kasson E; Singh AK; Huang M; Wu D; Cavazos-Rehg P
    Int J Med Inform; 2021 Nov; 155():104574. PubMed ID: 34592539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of a prescription model for accessing nicotine vaping products: an examination of submissions made by self-reported e-cigarette users to an Australian consultation.
    Jongenelis MI; Robinson A; Hughes A; Pettigrew S
    Health Promot Int; 2023 Aug; 38(4):. PubMed ID: 37555700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Is it banned? Is it illegal?": Navigating Western Australia's regulatory environment for e-cigarettes.
    McCausland K; Maycock B; Leaver T; Wolf K; Freeman B; Jancey J
    Int J Drug Policy; 2021 Aug; 94():103177. PubMed ID: 33713966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do people use electronic nicotine delivery systems (electronic cigarettes)? A content analysis of Twitter, 2012-2015.
    Ayers JW; Leas EC; Allem JP; Benton A; Dredze M; Althouse BM; Cruz TB; Unger JB
    PLoS One; 2017; 12(3):e0170702. PubMed ID: 28248987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.